Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gayle E. van der Kraaij"'
Autor:
Francisca M. Vermeulen, Gayle E. van der Kraaij, Ronald A. Tupker, Anne Bijlsma, Hans Blaauwbroek, Francine Das, Tessa Geltink, Josine S. van der Kraan, Renske Kranenburg, Dirk J. van der Veen, Kristie Venhorst, Phyllis I. Spuls
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 19, p adv00337 (2020)
In shared decision making (SDM) patients and physicians make treatment decisions together based on the best available evidence and the values and preferences of patients. SDM is very suitable for use in dermatological practice, but is infrequently
Externí odkaz:
https://doaj.org/article/a241e7135b164c78bcfada226da0d8b5
Autor:
Juul M.P.A. van den Reek, Lieke J. van Vugt, Martijn B.A. van Doorn, Gayle E. van der Kraaij, Wim J.A. de Kort, Georges P.H. Lucker, Barbara Horvath, M. David Njoo, H. Jorn Bovenschen, Paul M. Ossenkoppele, Marjolein S. De Bruin-Weller, Marjan de Groot, Roland Mommers, Ruud L.M.A. Prevoo, Peter C.M. van de Kerkhof, Phyllis I. Spuls, Wietske Kievit, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 98, Iss 7, Pp 648-654 (2018)
Interleukin 17-antagonist secukinumab demonstrated high efficacy for treatment of psoriasis in randomized controlled trials. However, performance in daily practice may differ from trials. Drug survival is a comprehensive outcome covering effectivenes
Externí odkaz:
https://doaj.org/article/b0da904a333c44fd885e51e01c2db934
Autor:
Astrid M. van Huizen, Gayle E. van der Kraaij, Celine I. Busard, Wouter Ouwerkerk, Juul M. P. A. van den Reek, Stef P. Menting, Errol P. Prens, Theo Rispens, Annick de Vries, Elke M. G. J. de Jong, Jo Lambert, Martijn B. A. van Doorn, Phyllis I. Spuls
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. Wiley-Blackwell
Background: Anti-drug antibodies (ADA) are formed in patients treated with adalimumab (ADL). This might increase clearance of ADL, potentially causing a (secondary) non-response. Combination therapy of ADL and methotrexate (MTX) reduces ADA levels an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8989400365164cff3deecae9549110ca
https://pure.eur.nl/en/publications/22e27fd2-be81-4892-b5a4-22c5e8733472
https://pure.eur.nl/en/publications/22e27fd2-be81-4892-b5a4-22c5e8733472
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 166
A 42-year-old man with no relevant medical history presented with a painless, red, disfiguring skin lesion located on the nose. He was diagnosed with lupus pernio, a rare, cutaneous subtype of sarcoidosis which is relatively resistant to therapy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7b82d94c235111cfd0f8ac74bba0b870
https://pubmed.ncbi.nlm.nih.gov/35899722
https://pubmed.ncbi.nlm.nih.gov/35899722
Autor:
Ronald A Tupker, Hans Blaauwbroek, Phyllis I. Spuls, Renske Kranenburg, Josine S van der Kraan, Tessa Geltink, Anne Bijlsma, F.M. Vermeulen, Dirk J van der Veen, Gayle E. van der Kraaij, Kristie Venhorst, Francine Das
Publikováno v:
Acta dermato-venereologica, 100(19):adv00337, 1-8. Society for the Publication of Acta Dermato-Venereologica
Acta Dermato-Venereologica, Vol 100, Iss 19, p adv00337 (2020)
Acta Dermato-Venereologica, Vol 100, Iss 19, p adv00337 (2020)
In shared decision making (SDM) patients and physi-cians make treatment decisions together based on the best available evidence and the values and preferences of patients. SDM is very suitable for use in dermatological practice, but is infrequently a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35fece079de12a2d1c9575b7ec68afe6
https://pure.amc.nl/en/publications/towards-more-shared-decision-making-in-dermatology-development-of-evidencebased-decision-cards-for-psoriasis-and-atopic-eczema-treatments(39759401-f3bd-4e90-b286-5ee96352c9fd).html
https://pure.amc.nl/en/publications/towards-more-shared-decision-making-in-dermatology-development-of-evidencebased-decision-cards-for-psoriasis-and-atopic-eczema-treatments(39759401-f3bd-4e90-b286-5ee96352c9fd).html
Autor:
Marjolein S. de Bruin-Weller, Marjan de Groot, P.M. Ossenkoppele, Juul M. P. A. van den Reek, G.P.H. Lucker, Phyllis I. Spuls, Peter C.M. van de Kerkhof, H Jorn Bovenschen, Gayle E. van der Kraaij, Wietske Kievit, Ruud L. M. A. Prevoo, Roland J M Mommers, Barbara Horváth, M. David Njoo, Wim J. A. de Kort, Martijn B. A. van Doorn, Elke M G J de Jong, Lieke J. van Vugt
Publikováno v:
Acta Dermato-Venereologica, 98(7), 648-654. Medical Journals/Acta D-V
Acta dermato-venereologica, 98(7-8), 648-654. Society for the Publication of Acta Dermato-Venereologica
Acta Dermato-Venereologica, 98, 7, pp. 648-654
Acta Dermato-Venereologica, Vol 98, Iss 7, Pp 648-654 (2018)
Acta Dermato-Venereologica, 98, 648-654
Acta dermato-venereologica, 98(7), 648-654. ACTA DERMATO-VENEREOLOGICA
Acta dermato-venereologica, 98(7-8), 648-654. Society for the Publication of Acta Dermato-Venereologica
Acta Dermato-Venereologica, 98, 7, pp. 648-654
Acta Dermato-Venereologica, Vol 98, Iss 7, Pp 648-654 (2018)
Acta Dermato-Venereologica, 98, 648-654
Acta dermato-venereologica, 98(7), 648-654. ACTA DERMATO-VENEREOLOGICA
Interleukin 17-antagonist secukinumab demonstrated high efficacy for treatment of psoriasis in randomized controlled trials. However, performance in daily practice may differ from trials. Drug survival is a comprehensive outcome covering effectivenes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46338124ad76cda5a77509fc2a081751
https://pure.eur.nl/en/publications/f57939c0-8ca9-4c64-bca1-4f36e2a8374a
https://pure.eur.nl/en/publications/f57939c0-8ca9-4c64-bca1-4f36e2a8374a